MRSA Drugs Market Segment to Reach USD 3.1 Billion by 2022
MRSA Drugs Market Analysis, by Drug Origin (semisynthetic and synthetic drugs), by Drug Class, By Key Companies (Allergan, Plc, Merck Inc, Pfizer, Savara Pharmaceuticals, Sealife Pharma) - Forecast to 2022
View full press release